Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Lipid Research|November 17, 2006
High-density genotyping and functional SNP localization in the CETP geneJohn F Thompson, Linda S Wood, Eve H Pickering, et al.
International Journal of Molecular Sciences|October 16, 2025
Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease PathwaysLi Xi, Elena Peeva, Yuji Yamaguchi, et al.
Plos One|January 19, 2012
Sequence analysis of the IL28A/IL28B inverted gene duplication that contains polymorphisms associated with treatment response in hepatitis C patientsJennifer M Reynolds, Sara A Paciga, Frances A Sanders, et al.
Scientific Reports|August 30, 2018
Self-report data as a tool for subtype identification in genetically-defined Parkinson's DiseaseAshley R Winslow, Craig L Hyde, Jemma B Wilk, et al.
Medical Care|October 28, 2016
Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database StudiesJigar R Desai, Craig L Hyde, Shaum Kabadi, et al.
Scientific Reports|March 12, 2022
Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1Daniel I Chasman, Craig L Hyde, Franco Giulianini, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohortJohn F Thompson, Craig L Hyde, Linda S Wood, et al.
Circulation. Cardiovascular Genetics|February 5, 2010
Genetic association of the CCR5 region with lipid levels in at-risk cardiovascular patientsCraig L Hyde, Alan Macinnes, Frances A Sanders, et al.
Nature Genetics|August 2, 2016
Identification of 15 genetic loci associated with risk of major depression in individuals of European descentCraig L Hyde, Michael W Nagle, Chao Tian, et al.
Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.
Pageof 3